Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated the listed location from Padua, Italy to Padova, Italy to reflect the official local name and maintain consistency in the site listings.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a system revision update: added Revision: v3.4.2 and removed Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the Study Protocol/Statistical Analysis Plan section.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.3.4 appears and v3.3.3 is removed. This is a minor metadata update that does not change the study details.SummaryDifference0.0%

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.